GENEVA, Oct. 28 -- SUN PHARMACEUTICAL INDUSTRIES, INC. (2 Independence WayPrinceton, New Jersey 08540) filed a patent application (PCT/US2025/014609) for "CRYSTALLINE FORM OF DEURUXOLITINIB" on Feb 05, 2025. With publication no. WO/2025/221338, the details related to the patent application was published on Oct 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WIEDEMANN, Sean (11 Cutting LnBurlington, Massachusetts 01803)

Abstract: The present disclosure is directed to polymorph Form 1 of 1H-pyrazole-1-propanenitrile, Beta-(cyclopentyl-2,2,3,3,4,4,5,5-d 8)-4-(7H-pyrrolo[2,3-d]pyrimidin-4-...